Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Tyra Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
TYRA
Nasdaq
8731
https://tyra.bio/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Tyra Biosciences Inc
Tyra Biosciences Inc (TYRA) Reports Increased R&D Investments Amid Pipeline Progress
- Mar 20th, 2024 1:01 am
Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights
- Mar 19th, 2024 8:05 pm
Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 9,152 Shares
- Mar 6th, 2024 4:27 am
Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 8,644 Shares
- Mar 1st, 2024 5:40 am
Tyra Biosciences to Present at Upcoming Investor Conferences
- Feb 27th, 2024 9:05 pm
Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference
- Feb 7th, 2024 9:05 pm
President and CEO Todd Harris Sells 100,000 Shares of Tyra Biosciences Inc (TYRA)
- Feb 7th, 2024 8:12 am
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
- Feb 2nd, 2024 1:00 pm
Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia
- Feb 1st, 2024 10:30 pm
16 Most Promising Long-Term Stocks According to Analysts
- Dec 29th, 2023 11:45 am
Tyra Biosciences Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300
- Dec 22nd, 2023 2:00 pm
Tyra Biosciences to Participate in 2023 Jefferies London Healthcare Conference
- Nov 8th, 2023 9:05 pm
Tyra Biosciences Reports Third Quarter 2023 Financial Results and Highlights
- Nov 7th, 2023 9:05 pm
Tyra Biosciences Announces Oral Presentations on TYRA-300 for Achondroplasia at the ASBMR and ASHG 2023 Annual Meetings
- Sep 21st, 2023 12:00 pm
We Think Tyra Biosciences (NASDAQ:TYRA) Can Afford To Drive Business Growth
- Sep 17th, 2023 12:02 pm
Tyra Biosciences to Participate at 2023 Cantor Global Healthcare Conference
- Sep 12th, 2023 8:05 pm
Tyra Biosciences Reports Second Quarter 2023 Financial Results and Highlights
- Aug 10th, 2023 8:05 pm
Tyra Biosciences Announces FDA Orphan Drug Designation for TYRA-300 for the Treatment of Achondroplasia
- Aug 1st, 2023 12:00 pm
Here's What Could Help Tyra Biosciences, Inc. (TYRA) Maintain Its Recent Price Strength
- Jun 16th, 2023 12:50 pm
Wall Street Analysts Think Tyra Biosciences, Inc. (TYRA) Could Surge 52.22%: Read This Before Placing a Bet
- Jun 7th, 2023 1:55 pm
Scroll